High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL)

Leukemia

Volumn 20, Issue 5, 2006, Pages 814-819

  Jabbour, E ^a   Koscielny, S ^a   Sebban, C ^b   Peslin, N ^a   Patte, C ^a   Gargi, T ^b   Biron, P ^b   Ferme C ^a   Bourhis, J H ^a   Vantelon, J M ^a   Arnaud, P ^a   Ribrag, V ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b CENTRE LÉON BÉRARD   (France)

Author keywords

LMT 98 regimen; Lymphoblastic lymphoma; Prognostic factor; T cell lymphoblastic leukemia

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; FOLINATE CALCIUM; LACTATE DEHYDROGENASE; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ADVANCED CANCER; ARTICLE; BONE MARROW CANCER; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOXICITY; ERYTHROCYTE TRANSFUSION; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; INFECTION; LACTATE DEHYDROGENASE BLOOD LEVEL; LYMPHOBLASTOMA; MALE; MINIMAL RESIDUAL DISEASE; MUCOSA INFLAMMATION; PLEURA EFFUSION; PRIORITY JOURNAL; SALVAGE THERAPY; SURVIVAL RATE; SURVIVAL TIME; T CELL LEUKEMIA; TREATMENT FAILURE; TUMOR LYSIS SYNDROME;

EID: 33646159545     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404156     Document Type: Article

References (22)

1. Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin's lymphomas: Clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol 1998; 16: 2780-2795.
2. Thomas D, Kantarjian H. Advances in the treatment of adult leukemia, Part II. Hematol Oncol Clin North Am 2001; 15: 51-95.
3. Coleman CN, Picozzi Jr VJ, Cox RS, McWhirter K, Weiss LM, Cohen JR et al. Treatment of lymphoblastic lymphoma in adults. J Clin Oncol 1986; 4: 1628-1637.
4. Picozzi Jr VJ, Coleman CN. Lymphoblastic lymphoma. Semin Oncol 1990; 17: 96-103.
5. Catovsky D, Goldman JM, Okos A, Frisch B, Galton DA. T-lymphoblastic leukaemia: A distinct variant of acute leukaemia. Br Med J 1974; 2: 643-646.
6. Bernard A, Boumsell L, Reinherz EL, Nadler LM, Ritz J, Coppin H et al. Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: Evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma. Blood 1981; 57: 1105-1110.
7. Le Gouill S, Lepretre S, Briere J, Morel P, Bouabdallah R, Raffoux E et al. Adult lymphoblastic lymphoma: A retrospective analysis of 92 patients under 61 years included in the LNH87/93 trials. Leukemia 2003; 17: 2220-2224.
8. Colgan JP, Andersen J, Habermann TM, Earle JD, O'Connell MJ, Neiman RS et al. Long-term follow-up of a CHOP-based regimen with maintenance therapy and central nervous system prophylaxis in lymphoblastic non-Hodgkin's lymphoma. Leuk Lymphoma 1994; 15: 291-296.
9. Nathwani BN, Diamond LW, Winberg CD, Kim H, Bearman RM, Glick JH et al. Lymphoblastic lymphoma: A clinicopathologic study of 95 patients. Cancer 1981; 48: 2347-2357.
10. Hoelzer D, Gökbuget N, Digel W, Faak T, Kneba T, Reutzel R et al. Leukemia GMSAAL: Outcome of adult patients with Tlymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia. Blood 2002; 99: 4379-4385.
11. Thomas DA, O'Brien SM, Cortes J, Giles FJ, Faderl S, Verstovsek S et al. Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma. Blood 2004; 104: 1624-1630.
12. Bernasconi C, Brusamolino E, Lazzarino M, Morra E, Pagnucco G, Orlandi E. Lymphoblastic lymphoma in adult patients: Clinicopathological features and response to intensive multiagent chemotherapy analogous to that used in acute lymphoblastic leukemia. Ann Oncol 1990; 1: 141-146.
13. Slater DE, Mertelsmann R, Koziner B, Higgins C, McKenzie S, Schauer P et al. Lymphoblastic lymphoma in adults. J Clin Oncol 1986; 4: 57-67.
14. Bouabdallah R, Xerri L, Bardou VJ, Stoppa AM, Blaise D, Sainty D et al. Role of induction chemotherapy and bone marrow transplantation in adult lymphoblastic lymphoma: A report on 62 patients from a single center. Ann Oncol 1998; 9: 619-625.
15. Zinzani PL, Bendandi M, Visani G, Gherlinzoni F, Frezza G, Merla E et al. Adult lymphoblastic lymphoma: Clinical features and prognostic factors in 53 patients. Leuk Lymphoma 1996; 23: 577-582.
16. Morel P, Lepage E, Brice P, Dupriez B, D'Agay MF, Fenaux P et al. Prognosis and treatment of lymphoblastic lymphoma in adults: A report on 80 patients. J Clin Oncol 1992; 10: 1078-1085.
17. Patte C, Kalifa C, Flamant F, Hartmann O, Brugieres L, Valteau-Couanet D et al. Results of the LMT81 protocol, a modified LSA2L2 protocol with high dose methotrexate, on 84 children with non-B-cell (lymphoblastic) lymphoma. Med Pediatr Oncol 1992; 20: 105-113.
18. Attarbaschi A, Mann G, Dworzak M, Wiesbauer P, Schrappe M, Gadner H. Mediastinal mass in childhood T-cell acute lymphoblastic leukemia: significance and therapy response. Med Pediatr Oncol 2002; 39: 558-565.
19. Murphy SB, Hustu HO. A randomized trial of combined modality therapy of childhood non-Hodgkin's lymphoma. Cancer 1980; 45: 630-637.
20. Milpied N, Ifrah N, Kuentz M, Maraninchi D, Colombat P, Blaise D et al. Bone marrow transplantation for adult poor prognosis lymphoblastic lymphoma in first complete remission. Br J Haematol 1989; 73: 82-87.
21. Baro J, Richard C, Sierra J, Garcia-Conde J, Garcia Larana J, Rocha E et al. Autologous bone marrow transplantation in 22 adult patients with lymphoblastic lymphoma responsive to conventional dose chemotherapy. Bone Marrow Transplant 1992; 10: 33-38.
22. Chopra R, Goldstone AH, Pearce R, Philip T, Petersen F, Appelbaum F et al. Autologous vs allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: A case-controlled analysis of the European Bone Marrow Transplant Group Registry data. J Clin Oncol 1992; 10: 1690-1695.